Literature DB >> 7314641

Stereoselective oxidation of styrene to styrene oxide in rats as measured by mercapturic acid excretion.

L P Delbressine, P J Van Bladeren, F L Smeets, F Seutter-Berlage.   

Abstract

1. Administration of styrene (I) and styrene oxide (II) to rats resulted in the excretion of 2-hydroxymercapturic acids, N-acetyl-S-(1-phenyl-2-hydroxyethyl)cysteine (III) and N-acetyl-S-(2-phenyl-2-hydrosyethyl)cysteine (IV). Each appeared to be a mixture of diastereoisomers. 2. Administration of optically pure styrene oxide resulted in formation of one set of diastereoisomers. Racemic styrene oxide gave equal amounts of diastereoisomers. Thus the opening of the epoxide ring by glutathione S-transferases was stereospecific and the transferases showed no preference for one of the isomers of styrene oxide. 3. After administration of styrene the observed ratio of the diastereoisomers for both hydroxymercapturic acids was about 1:4. This leads to the conclusion that there is a stereoselective oxidation of styrene to styrene oxide, with a preference for the R-isomer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7314641     DOI: 10.3109/00498258109045870

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  3 in total

1.  Pulmonary toxicity of inhaled styrene in acetone-, phenobarbital- and 3-methylcholanthrene-treated rats.

Authors:  E Elovaara; H Vainio; A Aitio
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  The applicability of the measurement of urinary thioethers. A study of humans exposed to styrene during diet standardization.

Authors:  L Aringer; A Löf; C G Elinder
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

3.  A note on individual differences in the urinary excretion of optical enantiomers of styrene metabolites and of styrene-derived mercapturic acids in humans.

Authors:  E Hallier; H W Goergens; H Karels; K Golka
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.